No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Pertuzumab plus trastuzumab significantly improves survival in metastatic breast cancer

byTeddy Guo

March 23, 2022

in StudyGraphics

Reading Time: 1 min read

Vaccine booster after Johnson & Johnson-Janssen priming are safe and immunogenic

RelatedReports

Chronic Disease

Impact of population based breast density notification: multisite parallel arm randomised controlled trial in BreastScreen

December 10, 2025

Many new pediatric asthma cases attributable to obesity

Chronic Disease

GLP-1 receptor agonists show little effect on obesity-related cancer risk

December 8, 2025

Lisinopril and carvedilol reduce cardiotoxicity in breast cancer patients receiving trastuzumab and anthracyclines

Cardiology

Biomarker-Guided Cardioprotection for Patients Treated With Anthracyclines

December 8, 2025

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

The Scan by 2 Minute Medicine®

World Health Organization warns that one in six infections now antibiotic resistant

October 23, 2025

Large proportion of late preterm infants and older admitted to the NICU

Neonatal hypoglycemia not significantly associated with lower educational achievement during childhood

Multiple variables related to physical activity levels in preschool children

Cardiosphere-derived cell therapy slows disease progression in Duchenne muscular dystrophy

Wellness Check: Spirituality

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports